• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    JRF Technology Debuts Elderberry Oral Film Strip

    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand

    Researchers Connect Gut Microbiome to Healthy Aging

    Carlson Launches New Grade of Astaxanthin Gummies with Astaferm
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    JRF Technology Debuts Elderberry Oral Film Strip

    House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19

    Gelita Discusses Bioactive Collagen Peptides and the E-sports Market

    FrieslandCampina Partners with Cayuga Milk Ingredients to Introduce Milk Proteins in U.S.
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    JRF Technology Debuts Elderberry Oral Film Strip

    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand

    Researchers Connect Gut Microbiome to Healthy Aging

    House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula

    Researchers Connect Gut Microbiome to Healthy Aging

    House Resolution Calls for CDC and FDA to Back Vitamin D for COVID-19

    Gelita Discusses Bioactive Collagen Peptides and the E-sports Market

    FrieslandCampina Partners with Cayuga Milk Ingredients to Introduce Milk Proteins in U.S.
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    AIDP

    Indena USA, Inc.

    Verdure Sciences

    Bioenergy Life Science, Inc. (BLS)

    Vesta Nutra
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Chenland Nutritionals Inc.

    Sabinsa Corporation

    Gencor

    Vesta Nutra

    Indena USA, Inc.
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Taking the Mystery Out of Medical Foods

    There are many regulatory factors to consider. Does your product qualify?

    Taking the Mystery Out of Medical Foods
    Related CONTENT
    • Windrose Partners LLC
    • How to Assess Risk in the Current Dietary Supplement Industry
    • Federal Judge Approves Consent Decree with Company that Sold Adulterated Products
    • Getting Ahead of the Curve: Mobility
    • Product Liability Insurance Rates Continue Steep Decline
    By Gregory Stephens, Windrose Partners04.02.18
    The medical foods market has grown to a multi-billion-dollar business and continues to expand in the U.S. and around the world. Globally, the market was valued at $12.3 billion in 2015 and is expected to grow at compound annual rate (CAGR) of 6.9% to 24.4 billion by 2025.

    Conditions associated with aging, Alzheimer’s disease, and diabetes, to name a few, are fueling growth. Advances in diagnosis and treatment favor the use of medical foods in conditions such as attention deficit disorder and kidney disease. The shift in patient management from inpatient to outpatient settings also supports the increased use of medical foods.

    Category Introduction
    Medical foods are not new to the U.S. market. The first product to use the term “medical food” was Lofenalac, a meal replacement product for the dietary management of people with PKU (phenylketonuria) who cannot metabolize the amino acid phenylalanine. In the U.S., Lofenalac and other medical foods were classified and regulated as drugs until passage of the Orphan Drug Act in 1988. The Orphan Drug Act created a category of nutritional therapeutics, separating them from drugs.

    The medical food category experienced significant growth in the late 1980s through the 1990s with the launch of products for the dietary management of, for instance, pulmonary and renal diseases. The FDA describes medical foods as specially formulated or processed foods designed for patients’ partial or sole source nutrition as part of an oral diet or by enteral feeding tube. While medical foods do not require FDA approval for commercial use, they must be used under the supervision of a physician for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.

    Existing medical foods may look like normal food but have an altered nutrient content, or they may be beverages, bars, pills, or tablets. They often can be categorized into one of the following categories:
    • Sole source nutrition products that provide all nutrients except the offending one. Lofenalac, for example, provides all nutrients except for the amino acid phenylalanine.
    • Other products may have an altered content of macronutrients (protein, carbohydrate, fat) to compensate for altered organ function.
    • Products that can be added to the usual diet to fulfill special nutritional needs.
    Lingering Questions & Controversies
    Even though regulations exist for certain aspects of medical foods, such as some labeling criteria, several elements remain unclear or controversial. These include:
    • Marketplace uncertainty regarding the difference between nutritional supplements and medical foods;
    • Confusion about the distinction between structure-function, disease management, and drug claims;
    • Absence of clear standards for clinical substantiation requirements of medical foods;
    • Difficulty in defining the distinctive nutritional requirements imposed by disease or health conditions necessitating use of medical foods;
    • A lack of clarity about what constitutes physician supervision and how medical foods are to be marketed to patients;
    • Limited third-party reimbursement for medical foods;
    • Lack of an FDA-approval process for medical foods; and
    • Most healthcare professionals have little knowledge about the availability of medical foods, their use, and regulations.
    These and other issues have made it difficult for companies hoping to develop and commercialize medical foods.

    Regulatory Complexity
    FDA’s final guidance document and FAQs on medical foods can be downloaded at http://bit.ly/2hYfDHR. Regarding this guidance, FDA clearly states that the documents “do not establish legally enforceable responsibilities. Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.”

    However, FDA has issued warning letters to several companies based on these guidances. The primary reason letters were issued was because companies have not demonstrated a “distinctive nutritional requirement” for the product.

    Clearly, compliance with FDA guidance about medical foods requires expert interpretation. A problem we often observe is that producers assume that if their product contributes to improved clinical outcomes, then it qualifies as a medical food. Common sense says this should be true; unfortunately, it is not.

    Without meeting the precise definition of a medical food as dictated by FDA, the agency would likely view such a product as an unapproved drug. Drug claims may not be made for medical foods. FDA requires that companies seeking to market a medical food must develop a persuasive argument to convince the agency and the medical community that:
    1. The product is especially formu lated/processed to meet distinctive nutritional requirements imposed by the disease or condition;
    2. The product is necessary to provide particular nutrients required by patients to achieve the expected outcome benefit; and
    3. The product is distinct from a dietary supplement intended for health maintenance.
    The Solution: The Medical Foods Qualification Assessment
    Companies often find they do not have the internal expertise to accomplish these stipulations. Windrose Partners has developed a process for screening potential products. Our Medical Food Qualification Assessment is not a comprehensive plan for new products. Rather, it is an initial evaluation of a product or concept that defines the potential for medical food status. If the product does not qualify according to the assessment, a gap analysis identifies items that, upon completion, increase the likelihood that the product can be marketed as a medical food.

    After establishing confidentiality, the Windrose Partners team of medical foods experts uses information provided about the product such as the following:
    • Product formulation, ingredient specifications, targeted indication, proposed form/application, proposed daily use, directions for use;
    • Relevant scientific and clinical research studies demonstrating safety and nutritional action.
    The team, made up of clinical, regulatory, business development, toxicology, and manufacturing experts, analyzes the following factors to determine a product’s potential to qualify as a medical food:
    • Product indication;
    • Product composition and intended use;
    • Presence of an established nutritional need which can be surmised for the indication and intended use;
    • Mechanism of action of the active ingredient(s);
    • Clinical study data supporting product composition and application to the particular condition(s);
    • Evidence in scientific and clinical literature supporting product use;
    • Ingredients are GRAS and meet FDA safety requirements for medical food use.
    Regulatory guidance about medical foods is not definitive, nor does it carry the force of law. While FDA approval is not required prior to product commercialization, it is possible for manufacturers to get warning letters saying that products do not meet FDA guidances. Use of a structured, organized process to qualify potential medical food products can serve as a valuable screening tool for companies that are considering this route to market. 


    Gregory Stephens
    Windrose Partners

    Greg Stephens, RD, is president of Windrose Partners, a company serving clients in the the dietary supplement, functional food and natural product industries. Formerly vice president of strategic consulting with The Natural Marketing Institute (NMI) and Vice President of Sales and Marketing for Nurture, Inc (OatVantage), he has 25 years of specialized expertise in the nutritional and pharmaceutical industries. His prior experience includes a progressive series of senior management positions with Abbott Nutrition (Ross Products Division of Abbott Laboratories), including development of global nutrition strategies for disease-specific growth platforms and business development for Abbott’s medical foods portfolio. He can be reached at 267-432-2696; E-mail: gregstephens@windrosepartners.com.
    Related Searches
    • Diabetes
    • Attention Deficit
    • Regulatory
    • Medical Food
    Related Knowledge Center
    • Medical Nutrition
    • Regulations
    Suggested For You
    Windrose Partners LLC Windrose Partners LLC
    How to Assess Risk in the Current Dietary Supplement Industry How to Assess Risk in the Current Dietary Supplement Industry
    Federal Judge Approves Consent Decree with Company that Sold Adulterated Products Federal Judge Approves Consent Decree with Company that Sold Adulterated Products
    Getting Ahead of the Curve: Mobility Getting Ahead of the Curve: Mobility
    Product Liability Insurance Rates Continue Steep Decline Product Liability Insurance Rates Continue Steep Decline
    Data from GMP Inspections Suggests Increased Compliance Data from GMP Inspections Suggests Increased Compliance
    Expect Changes for the Nutraceutical Industry in the Year Ahead Expect Changes for the Nutraceutical Industry in the Year Ahead
    State of the Industry: What Lies Ahead? State of the Industry: What Lies Ahead?
    FDA Considers Revoking Soy Protein’s Authorized Heart Health Claim FDA Considers Revoking Soy Protein’s Authorized Heart Health Claim
    When a Patent Is Not Enough: Product Commercialization Considerations When a Patent Is Not Enough: Product Commercialization Considerations
    Medical Foods Regulation: FDA’s Restrictive View Stifles Innovation Medical Foods Regulation: FDA’s Restrictive View Stifles Innovation
    UNPA Offers Education and Training for Food and Supplement Companies UNPA Offers Education and Training for Food and Supplement Companies

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      The Off-Label On Ramp

      The Off-Label On Ramp

      With an expanding base of clinical research supporting nutritional interventions, off label use of dietary supplements and medical foods is likely to grow.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 01.19.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      ‘Follow the Science’ Often Misses the Mark with Nutrition

      ‘Follow the Science’ Often Misses the Mark with Nutrition

      The mantra too often ignores common sense approaches to improving health and quality of life.
      By Todd Harrison, Venable 01.19.21

    • Dietary Supplements | Herbs & Botanicals | Regulations | World Markets
      CBD in Europe: News from the Front

      CBD in Europe: News from the Front

      A recent decision by the Court of Justice of the European Union has restored CBD’s status, and with it, the prospects of the entire industry.
      By Joerg Gruenwald, analyze & realize ag 01.19.21


    • Dietary Supplements | Regulations
      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Companies can be prepared by being thorough and transparent while going through insurance policy renewals.
      By Chris Morey, Bolton & Company 12.04.20

    • Dietary Supplements | Regulations
      A Business Perspective on Protecting Confidential Information: The NDA

      A Business Perspective on Protecting Confidential Information: The NDA

      Along with taking precautions in providing access to confidential information, a non-disclosure agreement can be a great way to protect your business.
      By Gregory Stephens, Windrose Partners 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations | Research | Vitamins
      Using All the Tools to Improve Public Health

      Using All the Tools to Improve Public Health

      Industry needs to make a stand in compelling authorities to communicate the value of nutrition and dietary supplementation.
      By Todd Harrison, Venable 11.09.20


    • Dietary Supplements | Regulations | World Markets
      Regulation Changes Calculus for Substance-Based Medical Devices

      Regulation Changes Calculus for Substance-Based Medical Devices

      The new regulation introduces more specific requirements for the technical documentation of this class of products.
      By Joerg Gruenwald, analyze & realize ag 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      Federal Regulators Slam Doctors for COVID-Related Communications

      Federal Regulators Slam Doctors for COVID-Related Communications

      Some practitioners were not selling or promoting products, they were simply suggesting certain natural substances might offer benefits in improving resilience.
      By Erik Goldman, Holistic Primary Care 10.01.20

    • Dietary Supplements | Regulations
      Nuance Claims? The Red Flags Around False Advertising, Intellectual Property & Mislabeling

      Nuance Claims? The Red Flags Around False Advertising, Intellectual Property & Mislabeling

      If you are a product formulator, label designer, or manufacturing facility, an Errors and Omissions policy is worth exploring.
      By Chris Morey, Bolton & Company 10.01.20


    • Immune Function | Regulations | Research | Vitamins
      Nutritional Status Has Critical Implications for Public Health

      Nutritional Status Has Critical Implications for Public Health

      Vitamin D, N-acetyl cysteine, and quercetin may have important roles to play in this pandemic.
      By Todd Harrison, Venable 09.08.20

    • Herbs & Botanicals | Regulations | World Markets
      CBD Regulatory Status Update in Europe

      CBD Regulatory Status Update in Europe

      Investing in a novel food application for hemp extracts or CBD derived from hemp is a risky proposition at present.
      By Joerg Gruenwald, analyze & realize ag 09.08.20

    • Dietary Supplements | Herbs & Botanicals | Quality & Safety | Regulations
      Potential Pitfalls for Hemp & CBD Products Within Liability Insurance Policies

      Potential Pitfalls for Hemp & CBD Products Within Liability Insurance Policies

      Companies need to account for risks and know what’s covered, but sometimes that’s not a cut-and-dry situation.
      By Chris Morey, Bolton & Company 07.15.20


    • Dietary Supplements | Healthcare Trends | Regulations
      Protecting Your Investment: A Business Perspective for Intellectual Property

      Protecting Your Investment: A Business Perspective for Intellectual Property

      Securing your IP can offer a competitive advantage in today’s marketplace, and may help attract marketing partners and financial investors.
      By Gregory Stephens, Windrose Partners 06.02.20

    • Healthcare Trends | Regulations | Vitamins
      Applying Common Sense: Nutritional Status Matters in this Pandemic

      Applying Common Sense: Nutritional Status Matters in this Pandemic

      Viruses are great equalizers, but a broken and backward healthcare system hasn’t helped.
      By Todd Harrison, Venable 06.02.20

    • Dietary Supplements | Regulations
      Insurance Premiums: When ‘Estimated Annual Revenue’ Misses the Mark

      Insurance Premiums: When ‘Estimated Annual Revenue’ Misses the Mark

      Every business is facing unprecedented challenges amid the COVID-19 pandemic.
      By Chris Morey, Bolton & Company 05.01.20

    Trending
    • Nestlé To Sell North American Water Brands
    • House Resolution Calls For CDC And FDA To Back Vitamin D For COVID-19
    • Innova: Top Trends In Dairy Focus On Holistic Benefits
    • Carlson Launches New Grade Of Astaxanthin Gummies With Astaferm
    • Omega-3s Recommended In Australian Pregnancy Guidelines Update
    Breaking News
    • Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    • JRF Technology Debuts Elderberry Oral Film Strip
    • Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    • Researchers Connect Gut Microbiome to Healthy Aging
    • Carlson Launches New Grade of Astaxanthin Gummies with Astaferm
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Clinical Trial Finds Metabolic Benefits for Polyphenols Formula
    JRF Technology Debuts Elderberry Oral Film Strip
    Danone Adds to Plant-Based Portfolio with Acquisition of Follow Your Heart Brand
    Coatings World

    Latest Breaking News From Coatings World

    OQ Chemicals Increases Carboxylic Acids, Esters Prices
    Sensory Analytics Announces Issuance of Broad New Patent Covering Coating Thickness Measurement
    Arkema Reports Full-year 2020 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Japan to Lead APAC Assisted Reproductive Technology Devices Market
    Portescap Slotless Brushless DC Motors Receive ISO 13485 Certification
    FDA Breakthrough Device Designation Given to MI Transcatheter Heart Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    High Purity New England Bolsters Biopharma Solutions Services
    AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
    CatSci Opens New Site in UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Biden Prioritizes PPP Relief for the Beauty Industry
    Christie Brinkley Joins SBLA Beauty
    Madison Reed Raises $52 Million in Financing Round
    Happi

    Latest Breaking News From Happi

    The Detox Market Partners with Good Face Project
    Peeps X HipDot Is Ready To Hatch
    MAC Cosmetics Launches Cream-to-Powder Foundation
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Lowe-Martin Adds 2 KODAK NEXFINITY Digital Presses
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    S-OneLP adds to growing team
    Avery Dennison expands automotive portfolio
    Amberley Labels turns to Kurz for embellishments
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Forbes Ranks Rockline Among Best U.S. Employers
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    NuVasive Nabs Simplify Medical for $150M
    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    RFID Locks Market to Reach $9.93 Billion by 2027: Allied Market Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login